Exact Mass: 437.1634

Exact Mass Matches: 437.1634

Found 77 metabolites which its exact mass value is equals to given mass value 437.1634, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pazopanib

5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide

C21H23N7O2S (437.1634)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor

   

186320-03-6

186320-03-6

C28H23NO4 (437.1627)


   

dichotomide X

dichotomide X

C23H23N3O6 (437.1587)


   

herdmanine A

herdmanine A

C22H23N5O5 (437.1699)


A natural product found in Herdmania momus.

   

Pazopanib

Pazopanib

C21H23N7O2S (437.1634)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor

   

E-4031

E-4031

C21H28ClN3O3S (437.154)


   

Cys Asn Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Cys Gln Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Cys Gln Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Cys Ser Gln Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Cys Ser Thr Gln

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.158)


   

Cys Thr Asn Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Cys Thr Gln Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Cys Thr Ser Gln

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.158)


   

Cys Thr Thr Asn

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.158)


   

Met Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Met Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Met Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.158)


   

Asn Cys Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Asn Met Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Asn Ser Met Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Asn Ser Ser Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O8S (437.158)


   

Asn Thr Cys Thr

(2S,3R)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Asn Thr Thr Cys

(2R)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.158)


   

Gln Cys Ser Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Gln Cys Thr Ser

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Gln Ser Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Gln Ser Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.158)


   

Gln Thr Cys Ser

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Gln Thr Ser Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.158)


   

Ser Cys Gln Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Ser Cys Thr Gln

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.158)


   

Ser Met Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Ser Met Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.158)


   

Ser Asn Met Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Ser Asn Ser Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O8S (437.158)


   

Ser Gln Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Ser Gln Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.158)


   

Ser Ser Met Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.158)


   

Ser Ser Asn Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O8S (437.158)


   

Ser Thr Cys Gln

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.158)


   

Ser Thr Gln Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.158)


   

Thr Cys Asn Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Thr Cys Gln Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Thr Cys Ser Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.158)


   

Thr Cys Thr Asn

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.158)


   

Thr Asn Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C15H27N5O8S (437.158)


   

Thr Asn Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.158)


   

Thr Gln Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H27N5O8S (437.158)


   

Thr Gln Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.158)


   

Thr Ser Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C15H27N5O8S (437.158)


   

Thr Ser Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.158)


   

Thr Thr Cys Asn

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H27N5O8S (437.158)


   

Thr Thr Asn Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O8S (437.158)


   

6-Hydroxy Doxazosin

[4-(4-amino-6-hydroxy-7-methoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone

C22H23N5O5 (437.1699)


   

7-Hydroxydoxazosin

7-Hydroxydoxazosin

C22H23N5O5 (437.1699)


   

Fmoc-3-(2-Naphthyl)-L-alanine

Fmoc-3-(2-Naphthyl)-L-alanine

C28H23NO4 (437.1627)


   

Fmoc-D-2-Nal-OH

Fmoc-D-2-Nal-OH

C28H23NO4 (437.1627)


   

H-Arg-Arg-NH2 · 3 HCl

H-Arg-Arg-NH2 · 3 HCl

C12H30Cl3N9O2 (437.1588)


   

Fmoc-3 (1 naphthyl)-L alanine; Fmoc-1-Nal-OH

Fmoc-3 (1 naphthyl)-L alanine; Fmoc-1-Nal-OH

C28H23NO4 (437.1627)


   

Fmoc-3-(1-Naphthyl)-L-alanine

Fmoc-3-(1-Naphthyl)-L-alanine

C28H23NO4 (437.1627)


   

benzyl 2-acetamido-2-deoxy-3,4,6-tri-o-acetyl-beta-d-glucopyranoside

benzyl 2-acetamido-2-deoxy-3,4,6-tri-o-acetyl-beta-d-glucopyranoside

C21H27NO9 (437.1686)


   

2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-NAPHTHALEN-2-YL-PROPIONIC ACID

2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-NAPHTHALEN-2-YL-PROPIONIC ACID

C28H23NO4 (437.1627)


   

C19H27N5O5S

C19H27N5O5S (437.1733)


   

Evogliptin hydrochloride

Evogliptin hydrochloride

C19H27ClF3N3O3 (437.1693)


   

N-(2-furanylmethyl)-1-[2-(2-hydroxyethoxy)ethyl]-2-imino-10-methyl-5-oxo-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxamide

N-(2-furanylmethyl)-1-[2-(2-hydroxyethoxy)ethyl]-2-imino-10-methyl-5-oxo-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxamide

C22H23N5O5 (437.1699)


   

1,3-Dimethyl-8-[methyl-(phenylmethyl)amino]-7-[2-(2-pyrimidinylthio)ethyl]purine-2,6-dione

1,3-Dimethyl-8-[methyl-(phenylmethyl)amino]-7-[2-(2-pyrimidinylthio)ethyl]purine-2,6-dione

C21H23N7O2S (437.1634)


   

1-(3-(2,4-Dimethylthiazol-5-YL)-4-oxo-2,4-dihydroindeno[1,2-C]pyrazol-5-YL)-3-(4-methylpiperazin-1-YL)urea

1-(3-(2,4-Dimethylthiazol-5-YL)-4-oxo-2,4-dihydroindeno[1,2-C]pyrazol-5-YL)-3-(4-methylpiperazin-1-YL)urea

C21H23N7O2S (437.1634)


   

1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C20H27N3O6S (437.162)


   

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C20H27N3O6S (437.162)


   

1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C20H27N3O6S (437.162)


   

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C20H27N3O6S (437.162)


   

ST 19:4;O7;Gly

ST 19:4;O7;Gly

C21H27NO9 (437.1686)


   

CTX-0294885

CTX-0294885

C22H24ClN7O (437.1731)


CTX-0294885 is a broad spectrum kinase inhibitor that can capture 235 kinases from MDA-MB-231 cells, and can capture all members of the AKT family. CTX-0294885 is a powerful reagent for analysis of kinome signaling networks that can be used for the research of diseases like inflammation, diabetes, and cancer[1].

   

(1s)-1-(8-hydroxy-3-{[(1z)-3-methoxy-3-oxoprop-1-en-1-yl]carbamoyl}-9h-pyrido[3,4-b]indol-1-yl)ethyl (2z)-2-methylbut-2-enoate

(1s)-1-(8-hydroxy-3-{[(1z)-3-methoxy-3-oxoprop-1-en-1-yl]carbamoyl}-9h-pyrido[3,4-b]indol-1-yl)ethyl (2z)-2-methylbut-2-enoate

C23H23N3O6 (437.1587)


   

(2r)-5-carbamimidamido-2-{[4-(1h-indole-3-carbonyloxy)phenyl]formamido}pentanoic acid

(2r)-5-carbamimidamido-2-{[4-(1h-indole-3-carbonyloxy)phenyl]formamido}pentanoic acid

C22H23N5O5 (437.1699)


   

1-{8-hydroxy-3-[(3-methoxy-3-oxoprop-1-en-1-yl)carbamoyl]-9h-pyrido[3,4-b]indol-1-yl}ethyl 2-methylbut-2-enoate

1-{8-hydroxy-3-[(3-methoxy-3-oxoprop-1-en-1-yl)carbamoyl]-9h-pyrido[3,4-b]indol-1-yl}ethyl 2-methylbut-2-enoate

C23H23N3O6 (437.1587)